Madam Speaker, it is hard to know where to begin with the speech the parliamentary secretary just gave. I have heard some of this before at rare diseases conferences. I just want people at home to know that not a single rare disease drug would be paid for through this legislation. That is for starters. It is only mentioned once in this entire piece of legislation. Second of all, the Canadian drug agency is not created. CADTH is being repurposed and renamed into the CDA.
My question, though, is specifically on rare diseases because the parliamentary secretary mentioned them. Of the $1.5 billion announced all the way back in 2019, $1.4 billion is still left unspent. Could the member tell me which rare disease drugs were covered between 2019 and today, which patients received the drugs and for what conditions?